These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29133766)

  • 1. Patient Education Improves Patient Knowledge and Acceptance on Antiviral Therapy of Hepatitis C in Rural China.
    Yang M; Rao HY; Feng B; Wu E; Wei L; Lok AS
    Chin Med J (Engl); 2017 Nov; 130(22):2750-2751. PubMed ID: 29133766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China].
    Yang M; Rao HY; Feng B; Wu E; Wei L; Lok AS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):824-828. PubMed ID: 30616316
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C in 2006.
    Williams R
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):309-11. PubMed ID: 16538099
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics and current management of hepatitis B and C in China.
    Sun YT; Zhang YX; Tang H; Mao Q; Wang XZ; Zhang LY; Chen H; Zhong YN; Lin SM; Zhang DZ
    World J Gastroenterol; 2014 Oct; 20(37):13582-90. PubMed ID: 25309089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prisoners, hard hit by hepatitis C, decry lack of access to drugs.
    Willyard C
    Nat Med; 2012 Nov; 18(11):1594-5. PubMed ID: 23135494
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of rapid viral suppression in the era of directly acting antiviral therapy for hepatitis C virus.
    Jenkins ET; Jensen DM
    Infect Dis Clin North Am; 2012 Dec; 26(4):879-91. PubMed ID: 23083821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic prospects in HCV treatment.
    Almasio PL; Ingrassia D; Vergara B; Filosto S
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):775-9. PubMed ID: 19053890
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
    Moorman AC; Xing J; Rupp LB; Gordon SC; Spradling PR; Boscarino JA; Schmidt MA; Daida YG; Teshale EH; Holmberg SD;
    Gastroenterology; 2018 Feb; 154(3):754-758. PubMed ID: 29360428
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C Virus: From Obscurity to the Lasker.
    Liang TJ
    Gastroenterology; 2016 Dec; 151(6):1052-1053. PubMed ID: 27765691
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin and hepatitis C therapy: useful adjuvant therapy but remember to treat the patient and not just a number.
    Yoshida EM; Dar Santos A; Partovi N; Ford JA
    Can J Gastroenterol; 2006 Aug; 20(8):519-20. PubMed ID: 16967572
    [No Abstract]   [Full Text] [Related]  

  • 12. Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?
    Luppi M; Barozzi P; Potenza L; Riva G; Morselli M; Torelli G
    Leukemia; 2004 Oct; 18(10):1572-5. PubMed ID: 15284857
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C Virus: Discovery to epitaph in a life-time.
    Aggarwal R
    Natl Med J India; 2017; 30(2):57-60. PubMed ID: 28816209
    [No Abstract]   [Full Text] [Related]  

  • 15. Eligibility criteria for antiviral therapy in HCV-positive patients: similar things to (almost) similar people.
    Giannini EG; Romagnoli P; Testa R
    Am J Gastroenterol; 2006 Feb; 101(2):406-7. PubMed ID: 16454854
    [No Abstract]   [Full Text] [Related]  

  • 16. New Antiviral Agents for Treatment of Hepatitis C.
    Egerman RS
    Clin Obstet Gynecol; 2019 Dec; 62(4):823-834. PubMed ID: 31094712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLA2R related primary membranous nephropathy in a hepatitis C positive patient.
    Ramachandran R; Yadav AK; Kumar V; Varma A; Taneja S; Nada R; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Mar; 23(3):288. PubMed ID: 29460999
    [No Abstract]   [Full Text] [Related]  

  • 18. Very late HCV relapse following triple therapy for hepatitis C.
    Barreiro P; Vispo E; Maida I; Aguilera A; Fernández-Montero JV; de Mendoza C; Labarga P; Soriano V
    Antivir Ther; 2014; 19(7):723-4. PubMed ID: 24535551
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiologic and therapeutic status study of patients with hepatitis C].
    Xu M; Shi HY; Cai WP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):135-6. PubMed ID: 21863640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future perspectives of hepatitis C therapeutics].
    Sakamoto N
    Hokkaido Igaku Zasshi; 2014 May; 89(1):13-15. PubMed ID: 25039102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.